Rep. Scott Fitzgerald

Maddy summaryThis bill sets new deadlines for the Federal Reserve Board to process applications from bank and savings holding companies seeking regulatory approvals. It requires the Board to notify applicants within 30 days (with a possible 30-day extension for complex cases) whether their application file is complete, and mandates a final decision within 90 days of submission - deeming the application approved if the deadline passes. The law restricts the Board from considering third-party information (like reports or recommendations) when determining if an application file is complete. It directly affects financial institutions applying for mergers, acquisitions, or other regulatory actions under the Bank Holding Company Act and Home Owners’ Loan Act. The key change is accelerating the approval process to reduce delays in the financial regulatory system.

Maddy summaryThis bill prohibits the Department of Labor from finalizing, implementing, or enforcing a specific proposed rule (published September 8, 2023) that would have raised the salary threshold for overtime eligibility for certain white-collar workers. It directly affects the Department of Labor's ability to move forward with that rule change. The bill does not create new overtime rules or alter current requirements; it simply blocks this particular proposed rule from taking effect. As a procedural measure, it prevents the rule from becoming final policy.

Maddy summaryHR 7248, the FDA Modernization Act 3.0, creates a new FDA process to qualify alternative nonclinical testing methods that can replace or reduce animal testing in drug development. Drug developers can request qualification for methods that improve safety/efficacy predictivity or shorten development time, with the FDA required to review requests within 180 days. If qualified, these methods allow expedited FDA review of drug applications and enable referencing the qualified method in submissions. The bill mandates annual reports tracking qualified methods, animal use reduction, and application approvals, with transparency requirements for Congress. This directly affects pharmaceutical companies and biotech firms developing new drugs.

Maddy summaryHJRES 114 is a joint resolution seeking congressional disapproval of a Federal Highway Administration (FHWA) rule that would have required tracking greenhouse gas emissions as part of assessing performance for the National Highway System. The rule, published in the Federal Register in December 2023, aimed to establish specific metrics for evaluating highway system performance, including emissions data. If approved, this resolution would nullify the rule, preventing the FHWA from implementing the emissions tracking requirement. This action directly affects how the FHWA measures highway system performance, specifically regarding environmental metrics.

Maddy summaryHR 7101, the FTC REDO Act, rescinds the Federal Trade Commission's (FTC) January 2024 rule targeting auto retail scams and prohibits the FTC from finalizing future auto retail rules without meeting specific requirements. Before proposing new rules, the FTC must conduct a quantitative study on deceptive practices, consumer testing on new mandates, and an economic analysis of costs/benefits - each subject to 30 days of public comment and independent peer review. These studies must demonstrate evidence of unfair practices, show new rules enhance consumer protection without unduly burdening businesses, and compare the proposed rule to less burdensome alternatives. The bill directly affects the FTC's rulemaking process for auto retail, impacting how regulations on dealerships, disclosures, and consumer protections are developed.

Maddy summaryThis bill repeals a law (18 U.S.C. § 1715) that previously prohibited mailing firearms without a license. It directly affects the U.S. Postal Service, firearm sellers, and individuals mailing firearms by preventing the Postal Service from creating rules that would block firearm mailings or require disclosure of sensitive records like sales receipts or firearm serial numbers. Key provisions include removing the existing ban on mailing firearms and prohibiting the Postal Service from imposing new restrictions on firearm mailings or demanding customer transaction data. The bill ensures that firearm mailings can proceed without these specific federal restrictions, while applying to ongoing legal cases under the repealed law.

Maddy summaryHR 7185 reauthorizes the High Intensity Drug Trafficking Areas (HIDTA) program through 2030, with specific focus on fentanyl. It allocates $302 million annually for HIDTA operations and adds $14.2 million yearly for grants to enhance fentanyl seizure efforts through competitive grants. The bill requires annual reports detailing fentanyl seizures and trafficking data, and directs the Attorney General to assign at least 16 assistant U.S. attorneys to prioritize fentanyl trafficking cases. This directly affects federal drug task forces, law enforcement agencies, and prosecutors working on fentanyl-related investigations.

Maddy summaryHR 2553, the "No More Political Prosecutions Act of 2023," amends a specific legal provision (Section 1442(a) of Title 28, U.S. Code) to exclude the President, Vice President, and former officials from being sued under that section. The bill removes existing language allowing civil or criminal cases against these officials and adds a new provision explicitly barring such actions. It applies to all pending cases or new prosecutions filed after the law's enactment. This change directly affects high-level federal officials by limiting legal challenges against them under this particular legal mechanism.

This bill designates the medical center of the Department of Veterans Affairs in Tomah, Wisconsin, as the Jason Simcakoski Department of Veterans Affairs Medical Center.

Maddy summaryHR 7092, the "Protecting Private Job Creators Act," exempts fixed-income securities from SEC Rule 15c2-11. This rule change specifically applies to securities like bonds, notes, debentures, and asset-backed securities used by businesses to raise capital. The bill codifies the SEC’s 2023 exemption of fixed-income securities sold under Rule 144A from Rule 15c2-11 requirements, which the SEC had previously applied without formal rulemaking. It directly affects businesses relying on fixed-income markets to access capital, ensuring they are not subject to the rule’s quotation disclosure requirements.